Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
CO

WKN: A2P5V6 | ISIN: SE0007784319 | Ticker: W5L
Frankfurt
18.11.26 | 20:15
0,039 Euro
+18,79 % +0,006
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CHOSA ONCOLOGY AB Chart 1 Jahr
5-Tage-Chart
CHOSA ONCOLOGY AB 5-Tage-Chart

Aktuelle News zur CHOSA ONCOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiSpotlight Stock Market: Market Notice 132/26 - Information regarding the rights issue from CHOSA Oncology AB1
MoThe Board of Directors of Chosa Oncology AB resolves on a rights issue of units of approximately SEK 2.5 million fully covered by pre-subscription commitments1
CHOSA ONCOLOGY Aktie jetzt für 0€ handeln
09.11.CHOSA ONCOLOGY AB: CHOSA's ESMO 2026 Expert Meeting Highlights the Unmet Need for Personalized Platinum Therapy in Lung Cancer1
04.11.Chosa Oncology AB: CHOSA enters into an agreement with a CLIA-certified laboratory partner for Platin-DRP in the USA - first revenue expected summer 2027534CHOSA enters into an agreement with a CLIA-certified laboratory partner for Platin-DRP in the USA - first revenue expected summer 2027 COPENHAGEN, Denmark, Nov. 4, 2026 /PRNewswire/ -- CHOSA Oncology...
► Artikel lesen
08.10.CHOSA ONCOLOGY AB: CHOSA receives 94 tumour samples from US patients to validate Platin-DRP in lung cancer chemo-immunotherapy-
27.08.CHOSA ONCOLOGY AB: CHOSA Oncology accelerates value creation by entering into a commercially driven licensing agreement with Aida Oncology2
15.07.CHOSA ONCOLOGY AB: Chosa Oncology announces the result of exercise of warrants TO21
13.07.CHOSA ONCOLOGY AB: Members of executive management participate in the ongoing warrant - exercise ending tomorrow1
10.07.CHOSA ONCOLOGY AB: CHOSA Oncology appoints US commercialization Bill Cronin with a broad network in the oncology market, to accelerate launch of Platin-DRP1
07.07.Spotlight Stock Market: Market Notice 76/26 - Last day of trading in CHOSA Oncology AB's subscription option CHOSA TO 21
01.07.CHOSA ONCOLOGY AB: CHOSA Oncology announces commencement of exercise period for TO2 warrants at the fixed price of SEK 0.782
23.06.CHOSA ONCOLOGY AB: CHOSA Oncology establishes US presence in Boston to support commercialization of Platin-DRP1
01.06.CHOSA ONCOLOGY AB: CHOSA and AIDA present data at ASCO 2026 showing up to 78% pathological complete response (pCR) rate in breast cancer using combined, integrated, taxane and platinum biomarkers4
01.06.CHOSA ONCOLOGY AB: CHOSA presents data at ASCO validating Platin-DRP on the NanoString platform showing significant overall survival prediction in Phase III lung cancer study1
27.05.Bulletin from the annual general meeting on 27 May 2026 in Chosa Oncology AB1
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1